H

Hansoh Pharmaceutical Group Company Ltd
HKEX:3692

Watchlist Manager
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Watchlist
Price: 41.98 HKD -0.19% Market Closed
Market Cap: 254.2B HKD

Relative Value

The Relative Value of one Hansoh Pharmaceutical Group Company Ltd stock under the Base Case scenario is 21.24 HKD. Compared to the current market price of 41.98 HKD, Hansoh Pharmaceutical Group Company Ltd is Overvalued by 49%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
21.24 HKD
Overvaluation 49%
Relative Value
Price
H
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
14
vs Industry
15
Median 3Y
8.4
Median 5Y
8.6
Industry
2.6
Forward
15.2
vs History
15
vs Industry
19
Median 3Y
27.1
Median 5Y
29.3
Industry
21.7
Forward
43.7
vs History
12
vs Industry
17
Median 3Y
27.9
Median 5Y
30.3
Industry
16.6
vs History
vs Industry
15
Median 3Y
22.5
Median 5Y
25.4
Industry
22.5
vs History
14
vs Industry
18
Median 3Y
3.4
Median 5Y
3.8
Industry
2.3
vs History
14
vs Industry
17
Median 3Y
6.3
Median 5Y
6.5
Industry
2.9
Forward
13.4
vs History
14
vs Industry
25
Median 3Y
6.9
Median 5Y
7.1
Industry
5.5
vs History
15
vs Industry
18
Median 3Y
19.9
Median 5Y
20.3
Industry
13.1
Forward
36.8
vs History
15
vs Industry
20
Median 3Y
22.4
Median 5Y
22.7
Industry
16.6
Forward
39.1
vs History
12
vs Industry
22
Median 3Y
20.3
Median 5Y
22.1
Industry
15.8
vs History
22
vs Industry
21
Median 3Y
22.5
Median 5Y
24.5
Industry
19.1
vs History
4
vs Industry
8
Median 3Y
8.3
Median 5Y
8.8
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Hansoh Pharmaceutical Group Company Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
249.7B HKD 17.2 47.5 36.3 39.2
US
Eli Lilly and Co
NYSE:LLY
934.9B USD 15.8 51 34.3 36.8
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
484.1B USD 5.3 19.3 15.8 20.5
CH
Roche Holding AG
SIX:ROG
251.1B CHF 4.1 26.8 11.5 13.4
UK
AstraZeneca PLC
LSE:AZN
210.8B GBP 4.8 29.9 108.2 158.3
CH
Novartis AG
SIX:NOVN
205B CHF 4.6 17.7 11.3 14.5
US
Merck & Co Inc
NYSE:MRK
241.5B USD 3.7 12.6 9 10.7
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK 4.2 12.8 8.9 10.4
IE
Endo International PLC
LSE:0Y5F
202.5B USD 87.3 -69.3 321.2 805.4
US
Pfizer Inc
NYSE:PFE
145.1B USD 2.3 14.8 7.5 10.3
P/E Multiple
Earnings Growth PEG
CN
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Average P/E: 25.8
47.5
14%
3.4
US
Eli Lilly and Co
NYSE:LLY
51
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.3
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.8
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
29.9
38%
0.8
CH
Novartis AG
SIX:NOVN
17.7
17%
1
US
Merck & Co Inc
NYSE:MRK
12.6
15%
0.8
DK
Novo Nordisk A/S
CSE:NOVO B
12.8
4%
3.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -69.3 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.8
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Average EV/EBITDA: 400.9
36.3
15%
2.4
US
Eli Lilly and Co
NYSE:LLY
34.3
33%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
15.8
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.5
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.2
10%
10.8
CH
Novartis AG
SIX:NOVN
11.3
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9
6%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
8.9
2%
4.5
IE
E
Endo International PLC
LSE:0Y5F
321.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
1%
7.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Average EV/EBIT: 1 711.1
39.2
17%
2.3
US
Eli Lilly and Co
NYSE:LLY
36.8
36%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.5
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.4
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.3
23%
6.9
CH
Novartis AG
SIX:NOVN
14.5
12%
1.2
US
Merck & Co Inc
NYSE:MRK
10.7
8%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
10.4
1%
10.4
IE
E
Endo International PLC
LSE:0Y5F
805.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.3
8%
1.3